Washington - The FDA advisory panel reviewing Hylaform and Restylane, the newest upstarts in the battle against wrinkles and scars, recommended each for approval, with conditions, by a 6-3 vote November 21.
Study Reports High Frequency of Emergency Complications During Dermatological, Surgical, and Cosmetic Procedures
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Exploring the Intersection of Permanent Makeup and Dermatology
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Facial Redness Reduction Cosmetics
Hands-on Workshop Empowers Clinicians in Cosmetic Dermatology